SENORES Share Price Today - Senores Pharmaceuticals on NSE/BSE

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,990.50	#1 4,77,587.63	41.71	#1 61,673.90	12.69	#1 11,565	25.80	66.37
Divis Laboratories	8,056.00	2,13,861.49	81.06	11,067.00	13.95	2,568	13.44	82.30
Torrent Pharmaceuticals	5,122.80	1,94,854.84	86.65	13,886.20	20.34	2,138	3.28	64.10
Cipla	1,473.20	1,19,011.77	35.29	29,044.60	2.24	3,870	-39.18	61.43
Zydus Life Science	1,126.80	1,13,382.45	21.72	27,657.90	17.64	5,026	7.82	53.10
Lupin	2,415.00	1,10,421.66	#1 20.65	29,038.90	#1 26.75	5,356	87.72	49.50
Mankind Pharma	2,469.60	1,01,993.49	51.48	14,636.40	14.85	1,938	29.13	44.89
Laurus Labs	1,816.20	98,048.75	88.28	6,867.80	22.01	890	#1 123.93	81.68
Dr Reddys Laboratories	1,148.10	95,828.36	30.00	35,058.60	3.90	4,158	-69.10	28.48
Aurobindo Pharma	1,580.20	90,921.21	26.12	33,384.70	3.21	3,376	1.99	57.35

Quarterly Financials	Dec 2023	Mar 2024	Jun 2024	Sept 2024	Dec 2024	Mar 2025	Jun 2025	Sept 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	80	104	80	100	108	126	134	159	178	193	183
Expenses	64	80	59	77	77	95	104	112	121	128	126
EBITDA	16	24	21	23	31	31	30	47	58	65	57
Operating Profit %	19 %	22 %	26 %	21 %	25 %	17 %	20 %	27 %	29 %	27 %	30 %
Depreciation	3	4	4	4	4	5	6	8	8	9	10
Interest	3	3	5	5	6	5	5	6	5	9	7
Profit Before Tax	10	18	14	16	21	21	27	41	45	47	40
Tax	3	3	3	3	4	3	5	11	11	11	9
Net Profit	7	14	11	13	16	18	21	30	34	37	31
EPS in ₹	4.01	8.03	3.39	3.92	5.04	3.81	4.60	6.54	7.29	7.96	6.61

Balance Sheet	2022	2023	2024	2025	2026
Total Assets	59	131	622	1,227	1,604
Fixed Assets	7	27	235	301	726
Current Assets	27	51	251	722	812
Capital Work in Progress	8	35	97	173	18
Investments	15	17	0	0	89
Other Assets	29	53	289	754	0
Total Equity & Liabilities	59	131	622	1,227	1,604
Current Liabilities	10	52	248	241	424
Non Current Liabilities	13	34	143	174	215
Total Equity	37	46	232	812	934
Reserve & Surplus	28	36	174	740	888
Share Capital	9	10	31	46	46

Cash Flow	2022	2023	2024	2025
Net Cash Flow	2	-3	8	98
Investing Activities	-24	-48	-54	-430
Operating Activities	-10	-1	-26	-46
Financing Activities	37	46	87	573

% Holding	Jul 2024	Sept 2024	Dec 2024	Mar 2025	Jun 2025	Sept 2025	Dec 2025	Mar 2026	Jun 2026
Promoter	66.66 %	45.76 %	45.76 %	45.77 %	45.78 %	45.80 %	45.80 %	45.82 %	45.82 %
FIIs	0.00 %	5.51 %	4.25 %	4.17 %	3.67 %	4.28 %	3.35 %	3.64 %	6.62 %
DIIs	0.00 %	18.61 %	11.78 %	9.65 %	9.51 %	8.61 %	9.31 %	9.61 %	9.77 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
Public / Retail	0.00 %	27.88 %	28.71 %	31.43 %	31.44 %	31.09 %	31.94 %	31.64 %	29.25 %
Others	33.34 %	2.23 %	9.49 %	8.97 %	9.60 %	10.22 %	9.59 %	9.30 %	8.55 %
No of Share Holders	177	43,707	43,707	37,653	36,389	34,917	34,401	34,126	36,498

Record Date	Corporate Action	Information	Announcement Day	LTP at Annoucement	LTP at Record Day
23 Jan 2025	Quarterly Result Announcement	NA	23 Jan 2025	530.80	498.50
15 May 2025	Quarterly Result Announcement	NA	15 May 2025	483.75	541.05
23 Jul 2025	Quarterly Result Announcement	NA	23 Jul 2025	617.55	616.35
18 Sept 2025	Annual General Meeting	NA	18 Sept 2025	717.85	689.25
06 Nov 2025	Quarterly Result Announcement	NA	06 Nov 2025	783.35	766.75
20 Jan 2026	Quarterly Result Announcement	NA	20 Jan 2026	812.35	806.55
31 Jan 2026	Extraordinary General Meeting	NA	31 Jan 2026	845.15	787.35
14 May 2026	Quarterly Result Announcement	NA	14 May 2026	932.45	977.10
27 Jul 2026	Quarterly Result Announcement	NA	27 Jul 2026	1,385.90	1,386.15

Funding House	Current Holding %	1M Change	1M Change %	3M Change %
TRUSTMF Mid Cap Fund Direct-Growth	0.78%	18415	0.78%	0.78%
HSBC India Export Opportunities Fund Direct-Growth	1.74%	0	0.00%	1.74%
HSBC Small Cap Fund Direct-Growth	0.45%	0	0.00%	0.14%
Bajaj Finserv Multi Asset Allocation Fund Direct-Growth	0.80%	0	0.00%	0.11%
Bajaj Finserv Small Cap Fund Direct-Growth	1.09%	0	0.07%	0.62%
Bandhan BSE Healthcare Index Fund Direct-Growth	0.21%	0	0.00%	0.02%
Bank of India Mid & Small Cap Equity & Debt Fund Direct-Growth	0.00%	0	0.00%	0.00%
Bank of India Multi Cap Fund Direct-Growth	0.00%	0	0.00%	0.00%
Bajaj Finserv Consumption Fund Direct-Growth	1.73%	0	0.00%	0.48%
Bajaj Finserv Healthcare Fund Direct-Growth	2.29%	0	0.00%	0.24%
HSBC Value Fund Direct-Growth	0.42%	0	0.00%	0.06%
HSBC Multi Cap Fund Direct-Growth	0.78%	0	0.00%	0.29%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth	0.00%	0	0.00%	0.00%
Mahindra Manulife Balanced Advantage Fund Direct-Growth	1.32%	0	0.00%	-0.04%
Mahindra Manulife Large & Mid Cap Fund Direct-Growth	2.09%	0	0.00%	0.01%
Bajaj Finserv Flexi Cap Fund Direct-Growth	0.20%	0	0.00%	0.12%
TRUSTMF Small Cap Fund Direct-Growth	1.63%	0	0.00%	0.58%
WhiteOak Capital Pharma and Healthcare Fund Direct-Growth	0.71%	0	0.00%	-0.10%

About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

Part of Raise Financial Services

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357 Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104

Senores Pharmaceuticals

Company News

Peer Comparison Compare Peers on Screener

Automatic Screeners on ScanX

Quarterly Financial Results

Balance Sheet

Cash Flow

Share Holding

Corporate Action

Announcements

Mutual Fund Holdings

Technical Indicators